TransEnterix, Inc. (NYSEAMERICAN:TRXC) shares were up 15.8% on Wednesday . The company traded as high as $0.34 and last traded at $0.39, approximately 95,570 shares were traded during mid-day trading. A decline of 96% from the average daily volume of 2,281,946 shares. The stock had previously closed at $0.34.
TransEnterix (NYSEAMERICAN:TRXC) last posted its quarterly earnings results on Monday, March 16th. The medical instruments supplier reported ($0.83) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.65) by ($0.18). The firm had revenue of $0.69 million for the quarter, compared to analysts’ expectations of $0.60 million.
In other TransEnterix news, Director Andrea Biffi bought 151,219 shares of the business’s stock in a transaction that occurred on Monday, February 24th. The stock was bought at an average cost of $1.24 per share, for a total transaction of $187,511.56. Following the completion of the transaction, the director now owns 199,738 shares of the company’s stock, valued at approximately $247,675.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
About TransEnterix (NYSEAMERICAN:TRXC)
TransEnterix, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.
Further Reading: Why Invest in Dividend Achievers?
Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.